Denali Therapeutics (DNLI) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.86
-0.77
-0.68
-0.59

Details

Expected EPS
-0.595062
Actual EPS
-0.63
Surprise EPS
-0.03
Surprise Percent
-5.87%

Description

⁨Denali Therapeutics⁩ (⁦DNLI⁩) has reported earnings of ⁦-0.63⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts